<?xml version="1.0" encoding="UTF-8"?>
<Label drug="naftin2" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    ADVERSE REACTIONS

  During clinical trials with Naftin  (r)  Gel, 1%, the incidence of adverse reactions was as follows: burning/stinging (5.0%), itching (1.0%), erythema (0.5%), rash (0.5%), skin tenderness (0.5%).
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
